English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Boehringer-Ingelheim
Carol Ostrow
| Dec 15, 2017
Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui
| Jun 14, 2017
Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson
| Feb 25, 2017
Combination therapy targets lung cancer
Carol Ostrow
| Feb 19, 2017
Partnership spurs efforts against COPD
Amanda Rupp
| Jun 28, 2016
Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp
| Jun 5, 2016
Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp
| May 31, 2016
Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp
| May 25, 2016
BioMed X, Boehringer Ingelheim partner for psychiatric treatments
Trending
+
Regulatory
Patient Daily News Service
| Jan 12, 2025
National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+
Regulatory
Patient Daily News Service
| Jan 16, 2025
FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'
+
Regulatory
Patient Daily reports
| Jan 14, 2025
National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
+
Pharmaceuticals
Patient Daily
| Jan 15, 2025
Dr. Peter Hotez receives 2025 Hill Prize for public health innovations
1
2
»
Last »
